CDA recommends funding for Alzheimer’s treatment
Canada’s Drug Agency is calling for the reimbursement of Lecanemab on public drug plans.

Connect with a community of people who care. Whether one-on-one counselling or support groups, we’re here for you.

Get answers to your questions about dementia including general information, resources, future planning and more.

Donate, volunteer, host an event — discover the many ways to build a community of care and compassion for those living with dementia.
Canada’s Drug Agency is calling for the reimbursement of Lecanemab on public drug plans.
A generous donation from The Jessiman Foundation will provide Manitobans faster access to dementia care over the next…
The Alzheimer Society Research Program announces the 2026 grant recipients.
11 am – 12 pm
10:30 – 11:30 am / Via Zoom
10 – 11:30 am
